The researchers found that extramedullary disease at diagnosis was significantly more common in patients with bone marrow fibrosis. Having myelofibrosis (MF) may predict the risk of developing ...
Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study Of the 3,522 patients enrolled, 282 were excluded, ...
CD19 chimeric antigen receptor (CAR) T-cell therapy achieved high response rates in patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) and extramedullary disease or central ...
A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in extramedullary multiple ...
The RedirecTT-1 trial showed a 78.9% response rate for talquetamab and teclistamab in relapsed multiple myeloma with extramedullary disease, significantly improving outcomes. INCA33989, a monoclonal ...
Add Yahoo as a preferred source to see more of our stories on Google. In vivo CAR-T therapies like KLN-1010 and ESOT-01 remain in early development. Credit: Krot ...
Mayo Clinic Researchers Find New Hope For Toughest Myeloma Through Off-The-Shelf Immunotherapy. A new Mayo Clinic study published in the New England Journal of Medicine has un ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results